stockrowMirum Pharmaceuticals, Inc. (MIRM) vs Scholar Rock Holding Corporation (SRRK)
- Mirum Pharmaceuticals, Inc. MIRM 93.82 +0.30%
- Scholar Rock Holding Corporation SRRK 46.94 +3.16%
Mirum Pharmaceuticals, Inc. and Scholar Rock Holding Corporation are both Biotechnology companies. Mirum Pharmaceuticals, Inc. is the larger, with a market value of $6.1B against $5.5B — 1.1× the size. Scholar Rock Holding Corporation grew revenue faster over the last twelve months: 213.7% against 42.2%. Scholar Rock Holding Corporation has the higher net margin (0.00% vs −134.8%) and the higher return on invested capital (0.00% vs −184.7%). Across the 16 metrics below, Scholar Rock Holding Corporation leads on 10 and Mirum Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | MIRM | SRRK | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.72% | 0.00% | 68.51% |
| Operating margin | (133.62%) | 0.00% | 0.00% |
| Net margin | (134.75%) | 0.00% | 0.00% |
| Free cash flow margin | (46.04%) | 0.00% | 0.00% |
| Return on equity | (760.01%) | (167.77%) | (51.96%) |
| Return on assets | (99.78%) | (94.63%) | (46.06%) |
| Return on invested capital | (184.65%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack